A single-piece hydrophobic acrylic IOL was associated with a significant increase in posterior capsule opacification up to 3 years and stabilization between 3 years and 5 years, according to a study.The prospective study included 390 eyes of 390 patien…
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Receives Second Unsolicited Acquisition Proposal for $0.35 per Share from a Global Pharmaceutical Company
(MedPage Today) — A searchable database of quality improvement projects may prevent duplication of efforts, suggests Fred N. Pelzman, MD
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/jb2qxk/proliferative) has announced the addition of the “Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H2 2015” report to their offering. This report p…
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph….
The District Court in The Hague, Netherlands, ruled that i-Optics is to refrain from using “misleading and defamatory advertisements” in reference to the Pentacam in the European Union, according to a press release from Oculus.The order against i-Optics includes a notification to be posted on its website for 2 months. The note reads: